|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:MLL-ELL (FusionGDB2 ID:54232) |
Fusion Gene Summary for MLL-ELL |
Fusion gene summary |
Fusion gene information | Fusion gene name: MLL-ELL | Fusion gene ID: 54232 | Hgene | Tgene | Gene symbol | MLL | ELL | Gene ID | 4297 | 8178 |
Gene name | lysine methyltransferase 2A | elongation factor for RNA polymerase II | |
Synonyms | ALL-1|CXXC7|HRX|HTRX1|MLL|MLL1|MLL1A|TRX1|WDSTS | C19orf17|ELL1|MEN|PPP1R68 | |
Cytomap | 11q23.3 | 19p13.11 | |
Type of gene | protein-coding | protein-coding | |
Description | histone-lysine N-methyltransferase 2ACXXC-type zinc finger protein 7lysine (K)-specific methyltransferase 2Alysine N-methyltransferase 2Amixed lineage leukemia 1myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila)trithorax-like | RNA polymerase II elongation factor ELLELL gene (11-19 lysine-rich leukemia gene)ELL/KMT2A fusionELL/KMT2A fusion proteinKMT2A/ELL fusionKMT2A/ELL fusion proteineleven-nineteen lysine-rich leukemia proteinelongation factor RNA polymerase IIprotein | |
Modification date | 20200319 | 20200319 | |
UniProtAcc | . | O00472 | |
Ensembl transtripts involved in fusion gene |